The Jayne Koskinas Ted Giovanis Foundation for Health and Policy (JKTG Foundation) funds cancer research, policy projects, and events that foster public discussion to improve the quality-of-care patients experience.
In 2022, JKTG Foundation work focuses on rethinking health care quality, emerging cancer research, and uses for real-world evidence. Of particular interest is building collaboration by fostering multi-institutional and multi-disciplinary research in the area of breast cancer metastasis.
The JKTG Foundation is honored to be supported by Team TGM, a championship-winning race team that competes in the IMSA Michelin Pilot Challenge.
Below are initiatives JKTG Foundation is supporting.
Research & Policy Analysis
- Continuing to fund collaborative, emerging cancer research that involves leading researchers with different areas of focus and background from organizations across the country.
- Funding collaborative, mathematical research projects that challenge traditional approaches to understanding cancer and cancer metastasis from hand-picked researchers across the country.
- Investigating new policy proposals and changes to Medicare and wider health care coverage with patients in mind, advocating against harmful rules, legislation, and policy that impact the quality-of-care patients’ experience including quality measures and incentives.
- Ongoing collaborative research to identify the underlying processes of how breast.
- Hosting the annual Jayne Koskinas Memorial Symposium featuring leading cancer researchers and fostering collaboration within health research disciplines.
- Convening clinician-researchers, policy analysts, reporters, patients, and others to facilitate candid dialog on key issues serving as an independent broker of ideas.
JKTG Founder and President Ted Giovanis, leading researchers, and University leaders gathered at the Johns Hopkins Welch Medical Library this week to formally mark the dedication of the Giovanis Institute for Translational Cell Biology – a symbolic first step of this important cancer research program.
Social Determinants of Health (SDoH) is all the rage as far as evaluating health. Stable housing, education, access to transportation, polluted water/air, etc. are all an important part of the discussion.
Medicare Part C, sometimes called Medicare Advantage, is touted as the efficient way to deliver quality care to enrollees. As someone on Medicare, I am not in a Medicare Part C. Why? Because I know better.